Oral Infigratinib Therapy in Children with Achondroplasia 무형성증 아동의 경구 인피그라티닙 요법
Oral Infigratinib Therapy in Children with Achondroplasia Abstract Achondroplasia is a genetic skeletal condition that results in disproportionately short stature and medical complications throughout life. Infigratinib is an orally bioavailable FGFR1-3 selective tyrosine kinase inhibitor in development for achondroplasia. The … Continued